revefenacin

FDA Drug Profile — YUPELRI

Drug Details

Generic Name
revefenacin
Brand Names
YUPELRI
Application Number
NDA210598
Sponsor
Viatris Specialty LLC
NDC Codes
1
Dosage Forms
SOLUTION
Routes
RESPIRATORY (INHALATION)
Active Ingredients
REVEFENACIN

Indications and Usage

1 INDICATIONS AND USAGE YUPELRI is indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD). YUPELRI is an anticholinergic indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD) .